// App-Quantinova.ai

2861 : Validation of PERK as an oncology target: A role for the unfolded protein response in cancer

Researchers

Presenter

  • Ken Dellamaggiore

Principal Investigators

  • Petia Mitchell

  • Ji-Rong Sun

  • Jeffrey Jones

  • Tony Muchamuel

  • David Hollenback

  • Seifu Tadesse

  • Shon Booker

  • Fang-Tsao Hong

  • Adrian Smith

  • Mark Rose

  • Pedro Beltran

  • James R. Lipford

Medical Centers

  • Amgen Inc, Thousand Oaks, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved